Quarter Period Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7550544

Concept 2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
Quarter period statement of income
Statement of income
Net sales
27,854,000,000 JPY
24,619,000,000 JPY
Cost of sales
15,621,000,000 JPY
13,580,000,000 JPY
Gross profit (loss)
12,232,000,000 JPY
11,039,000,000 JPY
Selling, general and administrative expenses
11,521,000,000 JPY
10,549,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
710,000,000 JPY
489,000,000 JPY
Non-operating income
Interest income
10,000,000 JPY
0 JPY
Dividend income
227,000,000 JPY
221,000,000 JPY
Non-operating income
253,000,000 JPY
310,000,000 JPY
Non-operating expenses
Interest expenses
16,000,000 JPY
17,000,000 JPY
Non-operating expenses
50,000,000 JPY
20,000,000 JPY
Ordinary profit (loss)
913,000,000 JPY
779,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
JPY
Extraordinary income
0 JPY
879,000,000 JPY
Extraordinary losses
Extraordinary losses
1,000,000 JPY
1,000,000 JPY
Profit (loss) before income taxes
913,000,000 JPY
1,658,000,000 JPY
Income taxes
236,000,000 JPY
474,000,000 JPY
Profit (loss)
676,000,000 JPY
1,183,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.